Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.74 |
| ▸ | MAPT | P10636 | 5/20 | 0.74 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.74 |
| ▸ | TSHR | P16473 | 4/20 | 0.74 |
| ▸ | MAOA | P21397 | 4/20 | 0.74 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.74 |
| ▸ | LMNA | P02545 | 3/20 | 0.74 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.74 |
| ▸ | MAOB | P27338 | 3/20 | 0.74 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.74 |
| ▸ | HPGD | P15428 | 3/20 | 0.74 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.74 |
| ▸ | HTT | P42858 | 1/20 | 0.74 |
| ▸ | BCL2 | P10415 | 1/20 | 0.73 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.73 |
| ▸ | MEN1 | O00255 | 5/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.70 |
| ▸ | ELANE | P08246 | 4/20 | 0.70 |
| ▸ | RECQL | P46063 | 3/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29928697 | 1.00 | ALDH1A1 (0.74) | ALDH1A1MAPTTDP1TSHRMAOA | |
| SCHEMBL29406720 | 0.94 | BCL2 (0.76) | ALDH1A1MAPTTDP1TSHRMAOA | |
| SCHEMBL3190101 | 0.94 | BCL2 (0.76) | ALDH1A1MAPTTDP1TSHRMAOA | |
| SCHEMBL16432715 | 0.86 | ELANE (0.67) | ALDH1A1MAPTTDP1TSHRMAOA | |
| SCHEMBL29596527 | 0.86 | ELANE (0.67) | ALDH1A1MAPTTDP1TSHRMAOA | |
| SCHEMBL29596416 | 0.86 | ELANE (0.67) | ALDH1A1MAPTTDP1TSHRMAOA | |
| Danthron SCHEMBL30544826 | 0.86 | MAPT (1.00) | ALDH1A1MAPTTDP1TSHRMAOA | |
| Danthron SCHEMBL29356886 | 0.86 | MAPT (1.00) | ALDH1A1MAPTTDP1TSHRMAOA | |
| Danthron SCHEMBL83688 | 0.86 | MAPT (1.00) | ALDH1A1MAPTTDP1TSHRMAOA | |
| SCHEMBL29390162 | 0.86 | ESR1 (0.77) | ALDH1A1MAPTTDP1TSHRMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119424397-A | Application of aloe-emodin in preparing medicine for treating pulmonary arterial hypertension | 大连医科大学 | 2025-02-14 | — | — | CN | claimed |
| EP-3280402-B1 | TOLAN COMPOUNDS FOR PROMOTING WOUND HEALING | BIOMENDICS LLC (US) | 2024-06-05 | — | — | EP | claimed |
| CN-119424397-A | Application of aloe-emodin in preparing medicine for treating pulmonary arterial hypertension | 大连医科大学 | 2025-02-14 | — | — | CN | disclosed |
| EP-3280402-B1 | TOLAN COMPOUNDS FOR PROMOTING WOUND HEALING | BIOMENDICS LLC (US) | 2024-06-05 | — | — | EP | disclosed |
| CN-118032745-A | Rhubarb vegetable dye and identification method of dyed fabric thereof | 上海中纺联和生态科技有限公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-107847466-B | Formulations and methods for modulating wound healing | 贝欧曼蒂克丝公司 | 2024-02-06 | — | — | CN | disclosed |
| US-11786481-B2 | Formulation and process for modulating wound healing | BioMendics, LLC (US) | 2023-10-17 | — | — | US | disclosed |
| US-11421223-B2 | Processes and host cells for genome, pathway, and biomolecular engineering | ENEVOLV, INC. (US) | 2022-08-23 | — | — | US | disclosed |
| US-20210380518-A1 | COMPOUNDS AND METHODS OF USING COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASES | Shekdar, Kambiz (US) | 2021-12-09 | — | — | US | disclosed |
| US-20210228501-A1 | Formulation and Process for Modulating Wound Healing | BioMendics, LLC (US) | 2021-07-29 | — | — | US | disclosed |
| US-20190309289-A1 | PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING | ENEVOLV, INC. | 2019-10-10 | — | — | US | disclosed |
| US-20160296477-A1 | Formulation and Process for Modulating Wound Healing | BioMendics, LLC (US) | 2016-10-13 | — | — | US | disclosed |
| US-20160186168-A1 | PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING | ENEVOLV, INC. | 2016-06-30 | — | — | US | disclosed |
| CN-105012412-A | Medicinal composition for treating kidney diseases and pharmaceutical use of medicinal composition | XI AN SHIJISHENGKANG PHARMACEUTICAL INDUSTRY CO LTD | 2015-11-04 | — | — | CN | disclosed |
| CN-104997855-A | Pharmaceutical composition containing total anthraquinone in rheum and total salvianolic acids and pharmaceutical application thereof | XI AN SHIJISHENGKANG PHARMACEUTICAL INDUSTRY CO LTD | 2015-10-28 | — | — | CN | disclosed |
| US-6150414-A | INHIBITING A VIRUS CAUSING INFECTION (SUCH AS HIV) BY ADMINISTERING THE COMPOUND 1,3,4,6-TETRAHYDROXY-7,16-DIOXO-7,16-DIHYDRO-DIBENZO(A,O)PERYLENE | NEW YORK UNIVERSITY (US) | 2000-11-21 | — | — | US | disclosed |
| EP-0426785-B1 | COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS | UNIV NEW YORK (US) | 1998-09-02 | — | — | EP | disclosed |
| EP-0426785-A4 | COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS | — | 1991-11-13 | — | — | EP | disclosed |
| EP-0426785-A1 | COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS | NEW YORK UNIVERSITY (US) | 1991-05-15 | — | — | EP | disclosed |
| WO-1990010438-A1 | COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS | NEW YORK UNIVERSITY (US) | 1990-09-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210380518-A1 | COMPOUNDS AND METHODS OF USING COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASES | ACE2, ACE, CFTR | ALDH1A1 2907/4885MAPT 2426/4885TDP1 4341/4885 |
| US-11786481-B2 | Formulation and process for modulating wound healing | SQSTM1, ATG7, TFEB | ALDH1A1 2877/4885MAPT 3534/4885TDP1 1811/4885 |
| US-20160296477-A1 | Formulation and Process for Modulating Wound Healing | SQSTM1, ATG7, TFEB | ALDH1A1 2491/4885MAPT 3766/4885TDP1 1661/4885 |
| US-20210228501-A1 | Formulation and Process for Modulating Wound Healing | ATG7, SQSTM1, ATF4 | ALDH1A1 2362/4885MAPT 3091/4885TDP1 730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.